New York Times (NYT) Financials

$52.69 +0.42 (+0.81%)

Closing price 03:59 PM Eastern

Extended Trading

$52.66 -0.03 (-0.06%)

As of 07:51 PM Eastern

Annual Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2015	12/25/2016	12/31/2017	12/30/2018	12/29/2019	12/27/2020	12/26/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	63	29	4.30	126	140	100	220	174	232	294
Consolidated Net Income / (Loss)	63	24	6.84	127	140	101	220	174	233	294
Net Income / (Loss) Continuing Operations	63	26	7.27	127	140	101	220	174	233	294
Total Pre-Tax Income	97	31	111	176	164	115	291	236	303	383
Total Operating Income	137	113	177	190	176	176	268	202	276	351
Total Gross Profit	961	926	1,413	796	824	824	1,035	1,099	1,177	1,276
Total Revenue	1,579	1,555	1,666	1,744	1,812	1,784	2,075	2,308	2,426	2,586
Operating Revenue	1,490	1,555	1,666	1,744	1,812	1,784	2,075	2,308	2,426	2,586
Total Cost of Revenue	618	629	253	948	988	959	1,040	1,209	1,249	1,310
Operating Cost of Revenue	618	629	253	948	988	959	1,040	1,209	1,249	1,310
Total Operating Expenses	825	813	1,236	606	648	648	767	897	901	925
Selling, General & Admin Expense	714	728	815	197	207	224	250	289	311	308
Marketing Expense	-	-	-	271	273	229	295	268	260	278
Research & Development Expense	-	-	-	84	106	133	161	204	229	248
Depreciation Expense	62	62	62	59	61	62	58	83	86	83
Other Operating Expenses / (Income)	49	6.73	359	-4.85	-2.05	0.00	0.00	15	-0.61	-2.98
Impairment Charge	-	-	-	-	-	0.00	0.00	4.07	15	0.00
Restructuring Charge	0.00	17	0.00	0.00	4.01	0.00	0.00	35	0.00	0.00
Other Special Charges / (Income)	0.00	-	-	-	0.00	0.00	3.83	0.00	0.00	11
Total Other Income / (Expense), net	-40	-82	-65	-14	-11	-61	22	34	26	32
Interest & Investment Income	-0.78	-36	19	11	0.00	5.00	0.00	41	24	36
Other Income / (Expense), net	-	-11	-64	-8.27	-7.30	-89	-10	-6.66	2.74	-4.16
Income Tax Expense	34	4.42	104	49	24	15	71	62	70	90
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.40	-5.24	2.54	1.78	0.00	0.73	0.00	0.00	0.37	0.00
Basic Earnings per Share	$0.38	$0.18	$0.03	$0.76	$0.84	$0.60	$1.31	$1.04	$1.41	$1.79
Weighted Average Basic Shares Outstanding	164.39M	161.13M	161.93M	164.85M	166.04M	166.97M	167.93M	166.87M	164.72M	164.43M
Diluted Earnings per Share	$0.38	$0.18	$0.03	$0.75	$0.83	$0.60	$1.31	$1.04	$1.40	$1.77
Weighted Average Diluted Shares Outstanding	166.42M	162.82M	164.26M	166.94M	167.55M	168.04M	168.53M	167.14M	165.66M	165.80M
Weighted Average Basic & Diluted Shares Outstanding	166.40M	161.50M	143.20M	165.40M	166.40M	167.44M	167.53M	164.47M	164.10M	163.30M
Cash Dividends to Common per Share	$0.16	$0.16	$0.16	$0.16	$0.20	$0.24	$0.28	$0.36	$0.44	$0.52

This table shows New York Times' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/25/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	37	71	22	47	54	110	40	66	64	124
Consolidated Net Income / (Loss)	37	71	22	47	54	110	40	66	64	124
Net Income / (Loss) Continuing Operations	37	71	22	47	54	110	40	66	64	124
Total Pre-Tax Income	51	94	32	61	70	140	56	87	85	156
Total Operating Income	51	93	28	56	64	129	48	79	77	147
Total Gross Profit	253	335	254	281	287	355	277	302	308	389
Total Revenue	548	668	561	591	598	676	594	625	640	727
Operating Revenue	548	668	561	591	598	676	594	625	640	727
Total Cost of Revenue	295	332	307	310	311	321	317	323	332	338
Operating Cost of Revenue	295	332	307	310	311	321	317	323	332	338
Total Operating Expenses	202	242	226	225	224	226	229	223	232	242
Selling, General & Admin Expense	72	77	81	72	82	76	79	77	76	76
Marketing Expense	65	62	67	62	63	68	65	61	69	83
Research & Development Expense	50	55	57	56	57	58	63	62	61	62
Depreciation Expense	22	22	21	22	21	22	21	21	21	21
Other Special Charges / (Income)	-	-	0.00	0.00	0.00	-	0.99	1.98	4.62	3.21
Total Other Income / (Expense), net	-0.18	0.68	3.86	5.20	6.42	11	7.34	7.67	8.32	9.00
Other Income / (Expense), net	-1.76	-1.76	0.69	0.68	0.68	0.68	-1.05	-1.02	-1.05	-1.03
Income Tax Expense	14	23	9.44	14	16	30	15	22	21	32
Basic Earnings per Share	$0.22	$0.42	$0.14	$0.28	$0.33	$0.66	$0.25	$0.40	$0.39	$0.75
Weighted Average Basic Shares Outstanding	166.43M	166.87M	164.98M	164.71M	164.57M	164.72M	164.63M	164.54M	164.42M	164.43M
Diluted Earnings per Share	$0.22	$0.42	$0.13	$0.28	$0.32	$0.67	$0.24	$0.40	$0.39	$0.74
Weighted Average Diluted Shares Outstanding	166.50M	167.14M	165.40M	165.04M	165.41M	165.66M	165.63M	165.51M	165.85M	165.80M
Weighted Average Basic & Diluted Shares Outstanding	165.42M	164.47M	164.68M	164.34M	164.41M	164.10M	164.31M	164.23M	163.95M	163.30M
Cash Dividends to Common per Share	$0.09	$0.18	$0.11	$0.11	$0.11	$0.11	$0.13	$0.13	$0.13	$0.13

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2015	12/25/2016	12/31/2017	12/30/2018	12/29/2019	12/27/2020	12/26/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-70	-8.68	75	60	-12	54	33	-97	68	-88
Net Cash From Operating Activities	179	104	87	157	190	298	269	151	361	411
Net Cash From Continuing Operating Activities	179	104	87	157	190	298	269	151	361	411
Net Income / (Loss) Continuing Operations	63	24	6.84	127	140	101	220	174	233	294
Consolidated Net Income / (Loss)	63	24	6.84	127	140	101	220	174	233	294
Depreciation Expense	62	62	62	59	61	62	58	83	86	83
Amortization Expense	-	-	-	0.00	7.38	8.57	9.49	9.92	9.23	9.09
Non-Cash Adjustments To Reconcile Net Income	58	48	-78	-35	-15	79	-20	0.76	53	52
Changes in Operating Assets and Liabilities, net	-3.84	-29	96	5.52	-2.80	47	2.35	-117	-20	-27
Net Cash From Investing Activities	-31	124	14	-101	93	-199	-181	-74	-160	-306
Net Cash From Continuing Investing Activities	-31	124	14	-101	93	-199	-181	-74	-160	-306
Purchase of Property, Plant & Equipment	-27	-30	-85	-77	-45	-34	-35	-37	-23	-29
Acquisitions	0.00	-40	-	0.00	0.00	-33	0.00	-516	0.00	0.00
Purchase of Investments	-824	-569	-467	-470	-572	-632	-763	-6.65	-286	-480
Sale and/or Maturity of Investments	818	725	564	446	708	498	614	483	145	191
Other Investing Activities, net	1.93	38	1.32	0.43	3.27	2.85	3.72	2.48	4.75	13
Net Cash From Financing Activities	-218	-237	-26	3.82	-295	-45	-55	-174	-133	-193
Net Cash From Continuing Financing Activities	-218	-237	-26	3.82	-295	-45	-55	-174	-133	-193
Repurchase of Common Equity	-69	-16	-	-	-	0.00	0.00	-105	-45	-85
Payment of Dividends	-27	-26	-26	-26	-32	-38	-45	-57	-70	-83
Other Financing Activities, net	-1.45	-6.44	0.54	31	-11	-6.54	-9.61	-12	-18	-25
Cash Interest Paid	41	0.04	28	28	28	0.51	0.55	1.58	0.71	0.72
Cash Income Taxes Paid	21	0.05	22	-1.07	30	24	66	110	72	113

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/25/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	30	30	14	10	-9.60	53	-82	17	-18	-5.01
Net Cash From Operating Activities	69	66	51	69	104	137	53	80	126	152
Net Cash From Continuing Operating Activities	69	66	51	69	104	137	53	80	126	152
Net Income / (Loss) Continuing Operations	37	71	22	47	54	110	40	66	64	124
Consolidated Net Income / (Loss)	37	71	22	47	54	110	40	66	64	124
Depreciation Expense	22	22	21	22	21	22	21	21	21	21
Amortization Expense	2.49	2.46	2.49	2.50	2.20	2.05	2.22	2.24	2.31	2.32
Non-Cash Adjustments To Reconcile Net Income	-7.14	36	12	12	7.90	22	10	13	8.96	20
Changes in Operating Assets and Liabilities, net	15	-65	-6.51	-13	19	-19	-20	-21	29	-16
Net Cash From Investing Activities	1.89	5.74	22	-27	-92	-62	-66	-30	-101	-109
Net Cash From Continuing Investing Activities	1.89	5.74	22	-27	-92	-62	-66	-30	-101	-109
Purchase of Property, Plant & Equipment	-8.80	-9.15	-5.99	-4.81	-5.75	-6.13	-6.42	-7.63	-7.06	-8.06
Purchase of Investments	-0.00	0.00	0.00	-44	-142	-100	-113	-72	-152	-143
Sale and/or Maturity of Investments	9.67	15	28	19	53	44	52	49	58	31
Other Investing Activities, net	1.03	-	0.00	2.30	2.45	-	0.55	0.81	-0.06	11
Net Cash From Financing Activities	-41	-41	-59	-32	-22	-21	-69	-34	-42	-48
Net Cash From Continuing Financing Activities	-41	-41	-59	-32	-22	-21	-69	-34	-42	-48
Repurchase of Common Equity	-25	-25	-31	-13	-	-0.96	-32	-9.55	-18	-25
Payment of Dividends	-15	-15	-15	-18	-18	-18	-19	-21	-21	-21
Other Financing Activities, net	-0.21	-0.90	-13	-0.63	-3.49	-1.47	-18	-2.70	-2.49	-2.02

This table presents New York Times' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2015	12/25/2016	12/31/2017	12/30/2018	12/29/2019	12/27/2020	12/26/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,418	2,185	2,100	2,197	2,089	2,308	2,564	2,534	2,715	2,841
Total Current Assets	863	796	750	894	717	836	953	656	782	936
Cash & Equivalents	106	101	183	242	230	286	320	221	289	199
Short-Term Investments	508	450	309	371	202	309	341	126	162	366
Accounts Receivable	207	197	185	222	213	184	233	218	242	250
Prepaid Expenses	19	16	23	25	29	29	33	55	60	50
Other Current Assets	23	33	50	33	42	27	26	36	28	71
Plant, Property, & Equipment, net	632	597	641	639	627	595	575	554	514	489
Total Noncurrent Assets	923	792	709	664	745	877	2,964	1,324	1,419	1,416
Long-Term Investments	314	203	241	214	252	287	413	139	258	346
Goodwill	109	135	144	140	139	172	166	414	416	412
Intangible Assets	-	-	-	-	-	-	14	317	285	258
Noncurrent Deferred & Refundable Income Taxes	309	301	153	128	115	100	96	96	115	111
Employee Benefit Assets	-	-	-	-	-	-	88	70	83	71
Other Noncurrent Operating Assets	191	154	171	182	240	319	2,187	288	262	218
Total Liabilities & Shareholders' Equity	2,418	2,185	2,100	2,197	2,089	2,308	2,564	2,534	2,715	2,841
Total Liabilities	1,589	1,341	1,202	1,154	915	980	1,023	934	951	914
Total Current Liabilities	564	399	416	673	438	487	559	571	612	614
Accounts Payable	96	104	125	112	117	123	127	115	117	124
Accrued Expenses	121	131	111	120	124	137	146	136	148	125
Current Employee Benefit Liabilities	98	96	105	105	109	121	166	165	174	178
Other Current Liabilities	-	-	75	84	88	105	119	156	173	187
Total Noncurrent Liabilities	1,026	942	787	481	478	493	464	363	340	301
Noncurrent Employee Benefit Liabilities	691	617	454	403	351	365	331	252	239	215
Other Noncurrent Operating Liabilities	92	79	82	78	126	128	133	111	101	86
Total Equity & Noncontrolling Interests	828	844	897	1,043	1,174	1,328	1,541	1,600	1,763	1,927
Total Preferred & Common Equity	827	848	897	1,041	1,172	1,326	1,539	1,598	1,763	1,927
Total Common Equity	827	848	897	1,041	1,172	1,326	1,539	1,598	1,763	1,927
Common Stock	163	167	181	224	226	234	248	273	319	374
Retained Earnings	1,329	1,332	1,310	1,506	1,613	1,673	1,845	1,959	2,118	2,325
Treasury Stock	-156	-171	-171	-171	-171	-171	-	-276	-321	-406
Accumulated Other Comprehensive Income / (Loss)	-509	-480	-423	-518	-495	-410	-383	-358	-353	-366

This table presents New York Times' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/25/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	2,515	2,472	2,479	2,547	2,623	2,673	2,762
Total Current Assets	543	634	675	658	681	716	795
Cash & Equivalents	190	235	246	236	207	223	205
Short-Term Investments	103	139	171	163	172	188	288
Accounts Receivable	164	166	159	164	178	181	189
Prepaid Expenses	59	58	61	57	59	50	45
Other Current Assets	28	35	38	39	65	73	68
Plant, Property, & Equipment, net	561	546	531	524	508	503	495
Total Noncurrent Assets	1,411	1,292	1,273	1,365	1,434	1,454	1,472
Long-Term Investments	176	100	94	189	307	313	327
Goodwill	406	415	415	413	415	414	417
Intangible Assets	329	310	303	293	278	272	265
Noncurrent Deferred & Refundable Income Taxes	112	106	116	116	121	128	131
Other Noncurrent Operating Assets	388	361	346	353	313	328	332
Total Liabilities & Shareholders' Equity	2,515	2,472	2,479	2,547	2,623	2,673	2,762
Total Liabilities	973	895	872	891	875	868	910
Total Current Liabilities	556	540	532	554	545	543	590
Accounts Payable	120	122	111	120	121	121	137
Accrued Expenses	139	155	125	140	157	123	129
Current Employee Benefit Liabilities	145	100	139	138	89	124	146
Other Current Liabilities	152	164	157	157	178	175	177
Total Noncurrent Liabilities	417	355	340	337	330	325	320
Noncurrent Employee Benefit Liabilities	304	249	246	240	236	233	230
Other Noncurrent Operating Liabilities	113	106	93	97	94	92	90
Total Equity & Noncontrolling Interests	1,542	1,577	1,607	1,655	1,748	1,805	1,852
Total Preferred & Common Equity	1,540	1,575	1,605	1,653	1,748	1,805	1,852
Total Common Equity	1,540	1,575	1,605	1,653	1,748	1,805	1,852
Common Stock	263	273	286	298	317	338	352
Retained Earnings	1,918	1,963	1,991	2,026	2,137	2,180	2,223
Treasury Stock	-251	-307	-	-320	-354	-	-382
Accumulated Other Comprehensive Income / (Loss)	-390	-354	-352	-351	-352	-350	-342

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2015	12/25/2016	12/31/2017	12/30/2018	12/29/2019	12/27/2020	12/26/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.59%	-1.51%	7.09%	4.72%	3.90%	-1.58%	16.33%	11.25%	5.10%	6.59%
EBITDA Growth	15.62%	-17.59%	6.68%	38.26%	-1.90%	-33.23%	105.66%	-11.30%	30.04%	17.26%
EBIT Growth	48.55%	-25.61%	10.59%	61.88%	-7.48%	-48.24%	195.69%	-24.17%	42.86%	24.35%
NOPAT Growth	-13.75%	8.62%	-88.02%	1,092.85%	8.56%	3.04%	31.82%	-26.67%	42.79%	26.61%
Net Income Growth	94.53%	-62.08%	-71.31%	1,764.27%	9.81%	-27.96%	118.15%	-20.94%	33.84%	26.24%
EPS Growth	90.00%	-52.63%	-83.33%	2,400.00%	10.67%	-27.71%	118.33%	-20.61%	34.62%	26.43%
Operating Cash Flow Growth	122.48%	-41.99%	-16.52%	81.19%	20.86%	56.89%	-9.68%	-44.00%	139.32%	13.84%
Free Cash Flow Firm Growth	-32.27%	-31.17%	-171.79%	226.69%	57.02%	52.87%	-982.08%	181.90%	-80.95%	13.06%
Invested Capital Growth	-11.44%	1.73%	22.65%	13.32%	4.27%	-8.95%	436.59%	-53.48%	-5.36%	-3.67%
Revenue Q/Q Growth	0.00%	-0.32%	2.54%	1.18%	0.39%	31.56%	-14.15%	3.28%	0.36%	1.99%
EBITDA Q/Q Growth	11.22%	-16.37%	-19.12%	26.24%	4.88%	-32.85%	39.45%	2.63%	11.46%	3.61%
EBIT Q/Q Growth	22.67%	-24.01%	-26.43%	37.85%	2.15%	-47.26%	56.82%	-0.09%	15.99%	4.80%
NOPAT Q/Q Growth	5.46%	8.30%	-88.55%	436.76%	13.74%	3.64%	1.35%	-0.56%	17.33%	5.80%
Net Income Q/Q Growth	39.66%	-37.09%	-93.32%	907.99%	8.73%	-36.30%	36.78%	0.52%	20.41%	4.81%
EPS Q/Q Growth	35.71%	-30.77%	-95.00%	837.50%	9.21%	-36.17%	39.36%	-0.95%	21.74%	4.12%
Operating Cash Flow Q/Q Growth	17.59%	-33.70%	-47.80%	184.67%	16.97%	8.35%	-10.54%	4.23%	24.45%	3.84%
Free Cash Flow Firm Q/Q Growth	-47.43%	-47.64%	-244.63%	176.43%	4.79%	25.59%	-857.39%	387.48%	45.26%	6.08%
Invested Capital Q/Q Growth	-5.85%	25.72%	27.71%	2.57%	5.13%	-2.40%	460.61%	3.72%	-1.26%	-1.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.88%	59.54%	84.83%	45.65%	45.47%	46.22%	49.90%	47.63%	48.52%	49.36%
EBITDA Margin	12.55%	10.50%	10.46%	13.81%	13.04%	8.85%	15.64%	12.47%	15.43%	16.98%
Operating Margin	8.65%	7.24%	10.60%	10.90%	9.69%	9.88%	12.92%	8.75%	11.39%	13.58%
EBIT Margin	8.65%	6.53%	6.75%	10.43%	9.29%	4.88%	12.41%	8.46%	11.50%	13.42%
Profit (Net Income) Margin	3.98%	1.53%	0.41%	7.31%	7.72%	5.65%	10.60%	7.53%	9.59%	11.36%
Tax Burden Percent	64.95%	78.07%	6.15%	72.38%	85.11%	87.36%	75.72%	73.69%	76.92%	76.63%
Interest Burden Percent	70.84%	30.04%	98.98%	96.81%	97.73%	132.53%	112.79%	120.83%	108.45%	110.52%
Effective Tax Rate	35.05%	14.48%	93.47%	27.62%	14.89%	12.64%	24.28%	26.31%	23.08%	23.37%
Return on Invested Capital (ROIC)	25.08%	28.75%	3.07%	31.12%	31.14%	32.90%	14.29%	8.49%	19.61%	26.00%
ROIC Less NNEP Spread (ROIC-NNEP)	31.17%	43.22%	4.02%	33.05%	32.64%	39.68%	-103.53%	22.16%	16.22%	22.95%
Return on Net Nonoperating Assets (RNNOA)	-17.00%	-25.90%	-2.28%	-17.98%	-18.51%	-24.84%	1.04%	2.59%	-5.77%	-10.08%
Return on Equity (ROE)	8.07%	2.85%	0.79%	13.14%	12.63%	8.06%	15.34%	11.07%	13.84%	15.92%
Cash Return on Invested Capital (CROIC)	37.21%	27.03%	-17.28%	18.63%	26.96%	42.26%	-122.87%	81.48%	25.11%	29.74%
Operating Return on Assets (OROA)	5.48%	4.41%	5.24%	8.47%	7.85%	3.96%	10.57%	7.66%	10.63%	12.49%
Return on Assets (ROA)	2.52%	1.04%	0.32%	5.93%	6.53%	4.59%	9.03%	6.82%	8.87%	10.58%
Return on Common Equity (ROCE)	8.05%	2.85%	0.79%	13.13%	12.61%	8.05%	15.31%	11.06%	13.83%	15.92%
Return on Equity Simple (ROE_SIMPLE)	7.60%	2.81%	0.76%	12.25%	11.94%	7.61%	14.30%	10.88%	13.20%	15.25%
Net Operating Profit after Tax (NOPAT)	89	96	12	138	149	154	203	149	213	269
NOPAT Margin	5.62%	6.20%	0.69%	7.89%	8.25%	8.63%	9.78%	6.45%	8.76%	10.40%
Net Nonoperating Expense Percent (NNEP)	-6.09%	-14.47%	-0.95%	-1.93%	-1.51%	-6.79%	117.83%	-13.67%	3.39%	3.06%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.30%	12.05%	13.96%
Cost of Revenue to Revenue	39.12%	40.46%	15.17%	54.35%	54.53%	53.78%	50.10%	52.37%	51.48%	50.64%
SG&A Expenses to Revenue	45.20%	46.83%	48.94%	11.27%	11.41%	12.53%	12.05%	12.53%	12.82%	11.91%
R&D to Revenue	0.00%	0.00%	0.00%	4.82%	5.87%	7.48%	7.75%	8.85%	9.43%	9.60%
Operating Expenses to Revenue	52.23%	52.29%	74.23%	34.75%	35.78%	36.33%	36.98%	38.88%	37.13%	35.78%
Earnings before Interest and Taxes (EBIT)	137	102	112	182	168	87	258	195	279	347
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	198	163	174	241	236	158	325	288	374	439
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.49	2.42	3.17	3.39	4.36	6.26	5.03	3.28	4.51	4.42
Price to Tangible Book Value (P/TBV)	2.87	2.88	3.77	3.92	4.95	7.19	5.69	6.05	7.49	6.77
Price to Revenue (P/Rev)	1.30	1.32	1.71	2.02	2.82	4.65	3.73	2.27	3.28	3.29
Price to Earnings (P/E)	32.56	70.72	662.05	28.06	36.53	82.92	35.15	30.15	34.22	28.97
Dividend Yield	1.26%	1.25%	0.91%	0.75%	0.62%	0.46%	0.59%	1.07%	0.87%	0.96%
Earnings Yield	3.07%	1.41%	0.15%	3.56%	2.74%	1.21%	2.84%	3.32%	2.92%	3.45%
Enterprise Value to Invested Capital (EV/IC)	4.71	4.57	5.70	6.29	9.04	16.64	2.78	4.27	6.87	7.49
Enterprise Value to Revenue (EV/Rev)	0.99	0.99	1.42	1.70	2.44	4.16	3.21	2.06	2.99	2.94
Enterprise Value to EBITDA (EV/EBITDA)	7.89	9.47	13.55	12.27	18.75	47.03	20.52	16.53	19.35	17.31
Enterprise Value to EBIT (EV/EBIT)	11.45	15.22	21.02	16.25	26.33	85.20	25.86	24.37	25.96	21.91
Enterprise Value to NOPAT (EV/NOPAT)	17.64	16.04	204.65	21.48	29.65	48.20	32.82	31.98	34.09	28.25
Enterprise Value to Operating Cash Flow (EV/OCF)	8.74	14.88	27.23	18.82	23.33	24.91	24.75	31.58	20.09	18.51
Enterprise Value to Free Cash Flow (EV/FCFF)	11.89	17.07	0.00	35.88	34.24	37.52	0.00	3.33	26.61	24.70
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.52	0.29	0.28	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.29	0.29	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.55	-0.60	-0.57	-0.54	-0.57	-0.63	-0.01	0.12	-0.36	-0.44
Leverage Ratio	3.20	2.75	2.46	2.21	1.93	1.76	1.70	1.62	1.56	1.51
Compound Leverage Factor	2.27	0.83	2.44	2.14	1.89	2.33	1.92	1.96	1.69	1.66
Debt to Total Capital	34.23%	22.63%	21.80%	19.57%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	14.95%	0.00%	0.00%	19.57%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.28%	22.63%	21.80%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.14%	-0.33%	0.01%	0.14%	0.16%	0.20%	0.13%	0.13%	0.00%	0.00%
Common Equity to Total Capital	65.63%	77.69%	78.19%	80.29%	99.84%	99.80%	99.87%	99.87%	100.00%	100.00%
Debt to EBITDA	2.18	1.51	1.44	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-2.50	-3.10	-2.77	-2.38	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	1.23	1.51	1.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	4.86	2.56	21.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-5.59	-5.25	-41.83	-4.16	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	2.74	2.56	21.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	2.53	2.86	3.45	3.98	5.73	7.18	6.87	5.66	7.42	8.18
Noncontrolling Interest Sharing Ratio	0.24%	-0.11%	-0.20%	0.10%	0.17%	0.18%	0.16%	0.13%	0.06%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.53	2.00	1.80	1.33	1.64	1.72	1.70	1.15	1.28	1.53
Quick Ratio	1.46	1.87	1.63	1.24	1.48	1.60	1.60	0.99	1.13	1.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	132	91	-65	82	129	198	-1,745	1,429	272	308
Operating Cash Flow to CapEx	664.10%	345.16%	102.31%	202.77%	417.90%	864.80%	776.91%	407.69%	1,590.80%	1,407.16%
Free Cash Flow to Firm to Interest Expense	3.37	2.60	-3.29	4.97	33.87	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	4.59	2.98	4.38	9.48	49.71	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	3.90	2.12	0.10	4.81	37.82	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.68	0.78	0.81	0.85	0.81	0.85	0.91	0.92	0.93
Accounts Receivable Turnover	7.52	7.69	8.71	8.56	8.32	8.98	9.96	10.25	10.55	10.51
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.43	2.53	2.69	2.73	2.86	2.92	3.55	4.09	4.54	5.16
Accounts Payable Turnover	6.49	6.28	2.20	8.00	8.66	8.00	8.31	10.00	10.79	10.89
Days Sales Outstanding (DSO)	48.52	47.47	41.88	42.62	43.89	40.63	36.64	35.61	34.60	34.72
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	56.27	58.15	166.09	45.64	42.13	45.61	43.93	36.49	33.84	33.52
Cash Conversion Cycle (CCC)	-7.75	-10.69	-124.21	-3.01	1.76	-4.98	-7.29	-0.88	0.77	1.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	332	338	415	470	490	446	2,394	1,114	1,054	1,015
Invested Capital Turnover	4.46	4.64	4.43	3.94	3.78	3.81	1.46	1.32	2.24	2.50
Increase / (Decrease) in Invested Capital	-43	5.77	77	55	20	-44	1,948	-1,280	-60	-39
Enterprise Value (EV)	1,565	1,546	2,362	2,956	4,431	7,421	6,660	4,759	7,244	7,601
Market Capitalization	2,059	2,056	2,844	3,527	5,113	8,301	7,733	5,244	7,953	8,512
Book Value per Share	$5.11	$5.26	$5.53	$6.31	$7.06	$7.93	$9.17	$9.66	$10.72	$11.75
Tangible Book Value per Share	$4.43	$4.43	$4.65	$5.46	$6.22	$6.90	$8.09	$5.24	$6.46	$7.67
Total Capital	1,260	1,091	1,148	1,296	1,174	1,328	1,541	1,600	1,763	1,927
Total Debt	431	247	250	254	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	243	247	250	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-496	-506	-483	-573	-684	-882	-1,074	-486	-709	-912
Capital Expenditures (CapEx)	27	30	85	77	45	34	35	37	23	29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-126	-153	-157	-139	-153	-246	-267	-263	-281	-243
Debt-free Net Working Capital (DFNWC)	487	397	334	474	279	349	394	84	170	323
Net Working Capital (NWC)	299	397	334	221	279	349	394	84	170	323
Net Nonoperating Expense (NNE)	26	73	4.70	10	9.47	53	-17	-25	-20	-25
Net Nonoperating Obligations (NNO)	-496	-506	-483	-573	-684	-882	853	-486	-709	-912
Total Depreciation and Amortization (D&A)	62	62	62	59	68	71	67	93	95	92
Debt-free, Cash-free Net Working Capital to Revenue	-7.98%	-9.82%	-9.45%	-7.94%	-8.45%	-13.80%	-12.89%	-11.39%	-11.60%	-9.40%
Debt-free Net Working Capital to Revenue	30.86%	25.55%	20.06%	27.19%	15.40%	19.57%	18.97%	3.66%	7.01%	12.48%
Net Working Capital to Revenue	18.93%	25.55%	20.06%	12.65%	15.40%	19.57%	18.97%	3.66%	7.01%	12.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	$0.18	$0.03	$0.76	$0.84	$0.60	$1.31	$1.04	$1.41	$1.79
Adjusted Weighted Average Basic Shares Outstanding	164.39M	161.13M	161.93M	164.85M	166.04M	166.97M	167.93M	166.87M	164.72M	164.43M
Adjusted Diluted Earnings per Share	$0.38	$0.18	$0.03	$0.75	$0.83	$0.60	$1.31	$1.04	$1.40	$1.77
Adjusted Weighted Average Diluted Shares Outstanding	166.42M	162.82M	164.26M	166.94M	167.55M	168.04M	168.53M	167.14M	165.66M	165.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	160.21M	161.20M	164.82M	165.92M	166.40M	167.44M	167.53M	164.47M	164.10M	163.30M
Normalized Net Operating Profit after Tax (NOPAT)	89	110	124	138	153	154	206	177	224	277
Normalized NOPAT Margin	5.62%	7.10%	7.42%	7.89%	8.43%	8.63%	9.92%	7.69%	9.24%	10.72%
Pre Tax Income Margin	6.13%	1.96%	6.68%	10.10%	9.08%	6.47%	14.00%	10.22%	12.47%	14.83%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.50	2.92	5.68	10.98	44.05	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	2.27	2.77	0.58	8.31	39.12	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	2.81	2.05	1.40	6.30	32.16	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	1.58	1.90	-3.70	3.63	27.22	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	42.33%	108.66%	380.34%	20.73%	22.58%	38.12%	20.61%	32.66%	30.00%	28.20%
Augmented Payout Ratio	152.59%	174.48%	380.34%	20.73%	22.58%	38.12%	20.61%	93.07%	49.14%	57.14%

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/25/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.58%	12.34%	4.34%	6.33%	9.25%	1.30%	5.93%	5.80%	6.99%	7.46%
EBITDA Growth	16.07%	6.85%	79.97%	14.92%	19.61%	33.41%	35.21%	25.18%	12.16%	9.95%
EBIT Growth	6.21%	-0.20%	500.27%	12.83%	30.44%	42.15%	65.36%	38.84%	17.78%	12.25%
NOPAT Growth	2.88%	-1.25%	285.49%	14.32%	32.53%	44.72%	78.94%	40.29%	18.84%	14.62%
Net Income Growth	-33.00%	1.28%	372.40%	-24.61%	46.42%	55.74%	81.07%	40.72%	19.64%	12.23%
EPS Growth	-31.25%	-2.33%	333.33%	-24.32%	45.45%	59.52%	84.62%	42.86%	21.88%	10.45%
Operating Cash Flow Growth	-30.51%	10.28%	446.07%	124.14%	51.46%	107.91%	4.63%	16.19%	20.31%	11.12%
Free Cash Flow Firm Growth	-1,026.79%	171.96%	88.65%	105.62%	109.01%	-88.05%	221.29%	132.89%	70.46%	-3.80%
Invested Capital Growth	151.46%	-53.48%	8.04%	0.93%	-0.58%	-5.36%	-3.69%	-1.44%	-3.35%	-3.67%
Revenue Q/Q Growth	-1.44%	21.88%	-16.00%	5.37%	1.27%	13.01%	-12.16%	5.23%	2.41%	13.50%
EBITDA Q/Q Growth	4.53%	56.74%	-54.94%	55.67%	8.79%	74.82%	-54.33%	44.12%	-2.52%	71.37%
EBIT Q/Q Growth	-1.56%	85.25%	-68.67%	97.51%	13.80%	101.89%	-63.56%	65.84%	-3.46%	92.40%
NOPAT Q/Q Growth	-1.40%	91.25%	-72.10%	117.25%	14.31%	108.84%	-65.50%	70.32%	-3.17%	101.43%
Net Income Q/Q Growth	-40.73%	93.31%	-68.47%	108.66%	15.12%	105.62%	-63.34%	62.16%	-2.13%	92.89%
EPS Q/Q Growth	-40.54%	90.91%	-69.05%	115.38%	14.29%	109.38%	-64.18%	66.67%	-2.50%	89.74%
Operating Cash Flow Q/Q Growth	123.57%	-4.66%	-22.74%	36.12%	51.07%	30.87%	-61.12%	51.15%	56.43%	20.87%
Free Cash Flow Firm Q/Q Growth	-5.67%	321.38%	-104.63%	151.96%	69.29%	193.65%	-53.05%	-0.22%	23.92%	65.72%
Invested Capital Q/Q Growth	-1.19%	3.72%	-1.02%	-0.50%	-2.68%	-1.26%	0.73%	1.82%	-4.56%	-1.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.16%	50.25%	45.28%	47.55%	48.00%	52.51%	46.66%	48.36%	48.16%	53.48%
EBITDA Margin	13.42%	17.26%	9.26%	13.68%	14.69%	22.73%	11.82%	16.18%	15.40%	23.26%
Operating Margin	9.31%	13.93%	4.98%	9.44%	10.62%	19.08%	8.13%	12.70%	11.99%	20.18%
EBIT Margin	8.99%	13.67%	5.10%	9.56%	10.74%	19.18%	7.96%	12.54%	11.82%	20.04%
Profit (Net Income) Margin	6.69%	10.60%	3.98%	7.88%	8.96%	16.30%	6.80%	10.48%	10.02%	17.03%
Tax Burden Percent	72.03%	75.56%	70.28%	76.38%	76.61%	78.82%	72.62%	75.26%	75.42%	79.49%
Interest Burden Percent	103.21%	102.67%	111.10%	108.00%	108.93%	107.83%	117.74%	111.09%	112.38%	106.89%
Effective Tax Rate	27.97%	24.44%	29.72%	23.62%	23.39%	21.18%	27.38%	24.74%	24.58%	20.51%
Return on Invested Capital (ROIC)	19.98%	13.86%	7.68%	15.63%	18.38%	33.67%	13.43%	21.89%	21.84%	40.09%
ROIC Less NNEP Spread (ROIC-NNEP)	20.00%	14.14%	7.11%	14.81%	17.45%	32.24%	12.51%	20.96%	20.95%	39.21%
Return on Net Nonoperating Assets (RNNOA)	-10.03%	1.65%	-2.20%	-4.53%	-5.76%	-11.46%	-4.37%	-7.58%	-8.41%	-17.22%
Return on Equity (ROE)	9.95%	15.51%	5.49%	11.10%	12.61%	22.21%	9.06%	14.31%	13.43%	22.87%
Cash Return on Invested Capital (CROIC)	-66.24%	81.48%	7.67%	14.57%	17.50%	25.11%	24.83%	23.96%	27.64%	29.74%
Operating Return on Assets (OROA)	8.07%	12.38%	4.75%	9.06%	10.26%	17.73%	7.68%	12.14%	11.29%	18.65%
Return on Assets (ROA)	6.00%	9.60%	3.71%	7.47%	8.56%	15.07%	6.57%	10.15%	9.57%	15.85%
Return on Common Equity (ROCE)	9.94%	15.49%	5.48%	11.08%	12.60%	22.19%	9.05%	14.30%	13.42%	22.87%
Return on Equity Simple (ROE_SIMPLE)	11.23%	0.00%	12.16%	10.98%	11.69%	0.00%	14.35%	14.95%	15.14%	0.00%
Net Operating Profit after Tax (NOPAT)	37	70	20	43	49	102	35	60	58	117
NOPAT Margin	6.71%	10.53%	3.50%	7.21%	8.14%	15.04%	5.91%	9.56%	9.04%	16.04%
Net Nonoperating Expense Percent (NNEP)	-0.02%	-0.28%	0.57%	0.82%	0.93%	1.43%	0.92%	0.94%	0.89%	0.88%
Return On Investment Capital (ROIC_SIMPLE)	-	4.39%	-	-	-	5.77%	-	-	-	6.05%
Cost of Revenue to Revenue	53.84%	49.75%	54.72%	52.45%	52.00%	47.49%	53.34%	51.64%	51.84%	46.52%
SG&A Expenses to Revenue	13.14%	11.50%	14.45%	12.23%	13.68%	11.22%	13.27%	12.30%	11.90%	10.46%
R&D to Revenue	9.22%	8.31%	10.18%	9.49%	9.60%	8.62%	10.64%	9.95%	9.53%	8.50%
Operating Expenses to Revenue	36.85%	36.31%	40.30%	38.11%	37.38%	33.43%	38.52%	35.66%	36.18%	33.30%
Earnings before Interest and Taxes (EBIT)	49	91	29	56	64	130	47	78	76	146
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	74	115	52	81	88	154	70	101	99	169
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.95	3.28	4.00	3.99	4.04	4.51	4.04	4.65	4.92	4.42
Price to Tangible Book Value (P/TBV)	5.65	6.05	7.41	7.21	7.06	7.49	6.70	7.50	7.79	6.77
Price to Revenue (P/Rev)	2.04	2.27	2.70	2.70	2.77	3.28	2.87	3.37	3.60	3.29
Price to Earnings (P/E)	26.30	30.15	32.86	36.30	34.58	34.22	28.21	31.15	32.58	28.97
Dividend Yield	1.17%	1.07%	0.94%	0.98%	0.98%	0.87%	1.02%	0.90%	0.86%	0.96%
Earnings Yield	3.80%	3.32%	3.04%	2.75%	2.89%	2.92%	3.54%	3.21%	3.07%	3.45%
Enterprise Value to Invested Capital (EV/IC)	3.80	4.27	5.28	5.37	5.71	6.87	6.01	7.09	8.05	7.49
Enterprise Value to Revenue (EV/Rev)	1.83	2.06	2.50	2.49	2.52	2.99	2.59	3.08	3.27	2.94
Enterprise Value to EBITDA (EV/EBITDA)	14.56	16.53	18.72	18.33	18.16	19.35	16.25	18.57	19.59	17.31
Enterprise Value to EBIT (EV/EBIT)	20.89	24.37	26.56	26.12	25.35	25.96	21.43	24.00	25.07	21.91
Enterprise Value to NOPAT (EV/NOPAT)	27.28	31.98	35.61	34.82	33.67	34.09	27.99	31.29	32.64	28.25
Enterprise Value to Operating Cash Flow (EV/OCF)	28.24	31.58	26.94	23.17	21.05	20.09	17.58	20.50	21.00	18.51
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	3.33	71.51	37.04	32.55	26.61	23.75	29.39	28.61	24.70
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.50	0.12	-0.31	-0.31	-0.33	-0.36	-0.35	-0.36	-0.40	-0.44
Leverage Ratio	1.66	1.62	1.63	1.59	1.58	1.56	1.53	1.51	1.51	1.51
Compound Leverage Factor	1.71	1.67	1.81	1.71	1.72	1.68	1.80	1.68	1.70	1.61
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.13%	0.13%	0.13%	0.12%	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.87%	99.87%	99.87%	99.88%	99.88%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.82	5.52	6.35	6.63	6.70	7.23	7.05	8.05	8.24	7.95
Noncontrolling Interest Sharing Ratio	0.13%	0.13%	0.13%	0.13%	0.13%	0.06%	0.06%	0.06%	0.06%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.98	1.15	1.17	1.27	1.19	1.28	1.25	1.32	1.35	1.53
Quick Ratio	0.82	0.99	1.00	1.08	1.02	1.13	1.02	1.09	1.16	1.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-610	1,350	-62	32	55	161	76	76	94	155
Operating Cash Flow to CapEx	782.33%	717.47%	847.62%	1,436.49%	1,815.17%	2,227.05%	826.26%	1,051.52%	1,777.45%	1,882.55%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.90	0.91	0.93	0.95	0.96	0.92	0.97	0.97	0.96	0.93
Accounts Receivable Turnover	13.62	10.25	12.83	14.13	14.76	10.55	14.31	14.66	14.37	10.51
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	3.92	4.09	4.17	4.31	4.46	4.54	4.67	4.82	4.98	5.16
Accounts Payable Turnover	9.71	10.00	9.21	11.06	10.53	10.79	10.38	10.98	10.06	10.89
Days Sales Outstanding (DSO)	26.80	35.61	28.45	25.83	24.73	34.60	25.50	24.90	25.41	34.72
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	37.60	36.49	39.65	32.99	34.66	33.84	35.17	33.25	36.27	33.52
Cash Conversion Cycle (CCC)	-10.81	-0.88	-11.20	-7.16	-9.93	0.77	-9.68	-8.35	-10.86	1.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,074	1,114	1,102	1,097	1,067	1,054	1,062	1,081	1,032	1,015
Invested Capital Turnover	2.98	1.32	2.20	2.17	2.26	2.24	2.27	2.29	2.42	2.50
Increase / (Decrease) in Invested Capital	647	-1,280	82	10	-6.26	-60	-41	-16	-36	-39
Enterprise Value (EV)	4,083	4,759	5,820	5,891	6,099	7,244	6,380	7,669	8,301	7,601
Market Capitalization	4,550	5,244	6,293	6,400	6,685	7,953	7,067	8,393	9,121	8,512
Book Value per Share	$9.27	$9.66	$9.57	$9.75	$10.06	$10.72	$10.62	$10.99	$11.28	$11.75
Tangible Book Value per Share	$4.84	$5.24	$5.17	$5.39	$5.76	$6.46	$6.41	$6.81	$7.13	$7.67
Total Capital	1,542	1,600	1,577	1,607	1,655	1,763	1,748	1,805	1,852	1,927
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-469	-486	-474	-510	-588	-709	-686	-724	-820	-912
Capital Expenditures (CapEx)	8.80	9.15	5.99	4.81	5.75	6.13	6.42	7.63	7.06	8.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-305	-263	-281	-274	-294	-281	-243	-238	-288	-243
Debt-free Net Working Capital (DFNWC)	-13	84	94	143	104	170	136	173	205	323
Net Working Capital (NWC)	-13	84	94	143	104	170	136	173	205	323
Net Nonoperating Expense (NNE)	0.13	-0.51	-2.71	-3.97	-4.92	-8.54	-5.33	-5.77	-6.27	-7.16
Net Nonoperating Obligations (NNO)	-469	-486	-474	-510	-588	-709	-686	-724	-820	-912
Total Depreciation and Amortization (D&A)	24	24	23	24	24	24	23	23	23	23
Debt-free, Cash-free Net Working Capital to Revenue	-13.66%	-11.39%	-12.04%	-11.58%	-12.17%	-11.60%	-9.86%	-9.56%	-11.34%	-9.40%
Debt-free Net Working Capital to Revenue	-0.56%	3.66%	4.03%	6.03%	4.31%	7.01%	5.55%	6.94%	8.10%	12.48%
Net Working Capital to Revenue	-0.56%	3.66%	4.03%	6.03%	4.31%	7.01%	5.55%	6.94%	8.10%	12.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.22	$0.42	$0.14	$0.28	$0.33	$0.66	$0.25	$0.40	$0.39	$0.75
Adjusted Weighted Average Basic Shares Outstanding	166.43M	166.87M	164.98M	164.71M	164.57M	164.72M	164.63M	164.54M	164.42M	164.43M
Adjusted Diluted Earnings per Share	$0.22	$0.42	$0.13	$0.28	$0.32	$0.67	$0.24	$0.40	$0.39	$0.74
Adjusted Weighted Average Diluted Shares Outstanding	166.50M	167.14M	165.40M	165.04M	165.41M	165.66M	165.63M	165.51M	165.85M	165.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	165.42M	164.47M	164.68M	164.34M	164.41M	164.10M	164.31M	164.23M	163.95M	163.30M
Normalized Net Operating Profit after Tax (NOPAT)	37	70	20	52	51	102	36	61	61	119
Normalized NOPAT Margin	6.71%	10.53%	3.50%	8.86%	8.46%	15.04%	6.03%	9.80%	9.58%	16.39%
Pre Tax Income Margin	9.28%	14.03%	5.66%	10.32%	11.70%	20.68%	9.37%	13.93%	13.28%	21.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	30.97%	32.66%	31.34%	35.79%	34.29%	30.00%	29.25%	28.41%	28.52%	28.20%
Augmented Payout Ratio	77.10%	93.07%	87.08%	89.21%	69.90%	49.14%	47.70%	44.34%	50.39%	57.14%

Frequently Asked Questions About New York Times' Financials

When does New York Times's financial year end?

According to the most recent income statement we have on file, New York Times' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has New York Times' net income changed over the last 9 years?

New York Times' net income appears to be on an upward trend, with a most recent value of $293.83 million in 2024, rising from $62.84 million in 2015. The previous period was $232.75 million in 2023. Find out what analysts predict for New York Times in the coming months.

What is New York Times's operating income?

New York Times's total operating income in 2024 was $351.10 million, based on the following breakdown:

Total Gross Profit: $1.28 billion
Total Operating Expenses: $925.31 million

How has New York Times revenue changed over the last 9 years?

Over the last 9 years, New York Times' total revenue changed from $1.58 billion in 2015 to $2.59 billion in 2024, a change of 63.7%.

How much debt does New York Times have?

New York Times' total liabilities were at $914.27 million at the end of 2024, a 3.9% decrease from 2023, and a 42.5% decrease since 2015.

How much cash does New York Times have?

In the past 9 years, New York Times' cash and equivalents has ranged from $100.69 million in 2016 to $319.97 million in 2021, and is currently $199.45 million as of their latest financial filing in 2024.

How has New York Times' book value per share changed over the last 9 years?

Over the last 9 years, New York Times' book value per share changed from 5.11 in 2015 to 11.75 in 2024, a change of 130.2%.

Related Companies

This page (NYSE:NYT) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New York Times (NYT) Financials

Frequently Asked Questions About New York Times' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

New York Times (NYT) Financials

Annual Income Statements for New York Times

Quarterly Income Statements for New York Times

Annual Cash Flow Statements for New York Times

Quarterly Cash Flow Statements for New York Times

Annual Balance Sheets for New York Times

Quarterly Balance Sheets for New York Times

Annual Metrics and Ratios for New York Times

Quarterly Metrics and Ratios for New York Times

Frequently Asked Questions About New York Times' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools